TGF-Β signaling plays an important role in resisting γ-irradiation

Experimental Cell Research

Volumn 319, Issue 4, 2013, Pages 466-473

  An, You Sun ^a   Kim, Mi Ra ^a   Lee, Seung Sook ^a   Lee, Yun Sil ^b   Chung, Eunkyung ^c   Song, Jie Young ^a   Lee, Jeeyong ^a   Yi, Jae Youn ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Ewha Womans University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Apoptosis; DNA damage; Smad; TGF 1; irradiation

Indexed keywords

CASPASE 3; HISTONE H2AX; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; RADIOPROTECTIVE AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; DNA FRAGMENTATION; FLOW CYTOMETRY; GAMMA IRRADIATION; IMMUNOFLUORESCENCE TEST; LUNG ALVEOLUS EPITHELIUM; MINK; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RADIATION PROTECTION; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; EVALUATION; GAMMA RADIATION; GENETIC TRANSFECTION; GENETICS; LUNG; METABOLISM; PHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE;

MUSTELA;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; EPITHELIAL CELLS; GAMMA RAYS; LUNG; MINK; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

MLCS; MLOWN;

EID: 84875548281     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.12.008     Document Type: Article

References (32)

1. Tang Y., Wu X., Lei W., Pang L., Wan C., Shi Z., Zhao L., Nagy T.R., Peng X., Hu J., Feng X., Van Hul W., Wan M., Cao X. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009, 15:757-765.
2. Sankar S., Mahooti-Brooks N., Bensen L., McCarthy T.L., Centrella M., Madri J.A. Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J. Clin. Invest. 1996, 97:1436-1446.
3. Pillaire M.J., Casagrande F., Malecaze F., Manenti S., Darbon J.M. Regulation by transforming growth factor-beta 1 of G1 cyclin-dependent kinases in human retinal epithelial cells. Exp. Eye Res. 1999, 68:193-199.
4. Heldin C.H., Miyazono K., ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390:465-471.
5. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
6. White R.A., Malkoski S.P., Wang X.J. TGF-beta signaling in head and neck squamous cell carcinoma. Oncogene 2010, 29:5437-5446.
7. Lampropoulos P., Zizi-Sermpetzoglou A., Rizos S., Kostakis A., Nikiteas N., Papavassiliou A.G. TGF-beta signalling in colon carcinogenesis. Cancer Lett. 2012, 314:1-7.
8. Akhurst R.J., Balmain A. Genetic events and the role of TGF beta in epithelial tumour progression. J. Pathol. 1999, 187:82-90.
9. Alexandrow M.G., Moses H.L. Kips off to Myc: implications for TGF beta signaling. J. Cell Biochem. 1997, 66:427-432.
10. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
11. Hsing A.Y., Kadomatsu K., Bonham M.J., Danielpour D. Regulation of apoptosis induced by transforming growth factor-beta1 in nontumorigenic rat prostatic epithelial cell lines. Cancer Res. 1996, 56:5146-5149.
12. Ashley D.M., Kong F.M., Bigner D.D., Hale L.P. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model. Cancer Res. 1998, 58:302-309.
13. Freathy C., Brown D.G., Roberts R.A., Cain K. Transforming growth factor-beta(1) induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form a approximately 700-kd apoptosome caspase-processing complex. Hepatology 2000, 32:750-760.
14. Schuster N., Krieglstein K. Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res. 2002, 307:1-14.
15. Ehata S., Hanyu A., Hayashi M., Aburatani H., Kato Y., Fujime M., Saitoh M., Miyazawa K., Imamura T., Miyazono K. Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res. 2007, 67:9694-9703.
16. Biswas S., Guix M., Rinehart C., Dugger T.C., Chytil A., Moses H.L., Freeman M.L., Arteaga C.L. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J. Clin. Invest. 2007, 117:1305-1313.
17. Ehrhart E.J., Segarini P., Tsang M.L., Carroll A.G., Barcellos-Hoff M.H. Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation. Faseb J. 1997, 11:991-1002.
18. Jobling M.F., Mott J.D., Finnegan M.T., Jurukovski V., Erickson A.C., Walian P.J., Taylor S.E., Ledbetter S., Lawrence C.M., Rifkin D.B., Barcellos-Hoff M.H. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radiat. Res. 2006, 166:839-848.
19. Zhu H.J., Sizeland A.M. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation. J. Biol. Chem. 1999, 274:11773-11781.
20. Souchelnytskyi S., Tamaki K., Engstrom U., Wernstedt C., ten Dijke P., Heldin C.H. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J. Biol. Chem. 1997, 272:28107-28115.
21. Goto D., Yagi K., Inoue H., Iwamoto I., Kawabata M., Miyazono K., Kato M. A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-beta signals. FEBS Lett. 1998, 430:201-204.
22. Abdollah S., Macias-Silva M., Tsukazaki T., Hayashi H., Attisano L., Wrana J.L. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 1997, 272:27678-27685.
23. Buckley S., Shi W., Barsky L., Warburton D. TGF-beta signaling promotes survival and repair in rat alveolar epithelial type 2 cells during recovery after hyperoxic injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2008, 294:L739-748.
24. Rancourt R.C., Hayes D.D., Chess P.R., Keng P.C., O'Reilly M.A. Growth arrest in G1 protects against oxygen-induced DNA damage and cell death. J. Cell Physiol. 2002, 193:26-36.
25. Kim A.H., Lebman D.A., Dietz C.M., Snyder S.R., Eley K.W., Chung T.D. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33. Int. J. Oncol. 2003, 23:1593-1599.
26. Bouquet F., Pal A., Pilones K.A., Demaria S., Hann B., Akhurst R.J., Babb J.S., Lonning S.M., DeWyngaert J.K., Formenti S.C., Barcellos-Hoff M.H. TGF-beta1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin. Cancer Res. 2011, 17:6754-6765.
27. Ewan K.B., Henshall-Powell R.L., Ravani S.A., Pajares M.J., Arteaga C., Warters R., Akhurst R.J., Barcellos-Hoff M.H. Transforming growth factor-beta1 mediates cellular response to DNA damage in situ. Cancer Res. 2002, 62:5627-5631.
28. Kirshner J., Jobling M.F., Pajares M.J., Ravani S.A., Glick A.B., Lavin M.J., Koslov S., Shiloh Y., Barcellos-Hoff M.H. Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress. Cancer Res. 2006, 66:10861-10869.
29. Ju E.M., Choi K.C., Hong S.H., Lee C.H., Kim B.C., Kim S.J., Kim I.H., Park S.H. Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt. Biochem. Biophys. Res. Commun. 2005, 328:1170-1181.
30. Gong J., Ammanamanchi S., Ko T.C., Brattain M.G. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Cancer Res. 2003, 63:3340-3346.
31. Bornstein S., White R., Malkoski S., Oka M., Han G., Cleaver T., Reh D., Andersen P., Gross N., Olson S., Deng C., Lu S.L., Wang X.J. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J. Clin. Invest. 2009, 119:3408-3419.
32. Biswas S., Criswell T.L., Wang S.E., Arteaga C.L. Inhibition of transforming growth factor-beta signaling in human cancer: targeting a tumor suppressor network as a therapeutic strategy. Clin. Cancer Res. 2006, 12:4142-4146.